Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-02 4:30 pm Purchase | 2022-04-21 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 93,333 8.080% | 93,333 (New Position) | Filing History |
| 2022-03-08 08:58 am Purchase | 2022-03-01 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Moshe Arkin | 60,874 5.380% | 60,874 (New Position) | Filing History |
| 2022-02-11 6:34 pm Purchase | 2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management, LLC | 110,000 9.700% | 20,547 (+22.97%) | Filing History |
| 2022-02-11 5:23 pm Sale | 2021-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 139 13.000% | -55,431 (-99.75%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 82,432 7.300% | 3,256 (+4.11%) | Filing History |
| 2022-01-21 3:25 pm Purchase | 2021-12-27 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 234,961 20.750% | 39,639 (+20.29%) | Filing History |
| 2021-09-10 10:31 am Purchase | 2021-08-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 195,322 17.260% | 64,594 (+49.41%) | Filing History |
| 2021-08-06 4:30 pm Sale | 2021-08-05 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 55,570 4.910% | -4,000 (-6.71%) | Filing History |
| 2021-02-16 3:18 pm Purchase | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | 683 Capital Management, LLC | 89,453 8.200% | 89,453 (New Position) | Filing History |
| 2021-02-12 4:30 pm Unchanged | 2020-12-31 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Vivo Ventures VI LLC | 59,570 5.500% | 0 (Unchanged) | Filing History |
| 2021-02-11 08:25 am Sale | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | ADAGE CAPITAL PARTNERS GP L.L.C. | 0 0.000% | -74,167 (Position Closed) | Filing History |
| 2021-01-29 09:56 am Purchase | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | BlackRock Inc. BLK | 79,176 7.300% | 16,186 (+25.70%) | Filing History |
| 2021-01-11 11:46 am Purchase | 2020-12-31 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | AMERIPRISE FINANCIAL INC AMP | 130,728 12.060% | 130,728 (New Position) | Filing History |
| 2021-01-04 11:29 am Sale | 2021-01-04 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Broadfin Capital LLC | 0 0.000% | -41,212 (Position Closed) | Filing History |